| abstract |
IgE antibody production inhibitors and autoimmune diseases inhibitors characterized by containing as the active ingredient heterocyclic amide compounds represented by general formula (1) or pharmacologically acceptable salts thereof, wherein R represents hydrogen, alkyl, -CHO, -COOH, etc.; R5, R6 and R7 represent each hydrogen, alkyl, aryl, etc.; M represents carbon or nitrogen; Y represents aryl, etc.; and Z represents hydrogen, alkyl, aryl, etc. |